Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-5,800
Closed -$359K 194
2016
Q2
$359K Buy
5,800
+5,735
+8,823% +$349K 0.02% 493
2016
Q1
$371K Sell
65
-20
-24% -$1.11K 0.01% 411
2015
Q4
$504K Sell
85
-77
-48% -$4.43K 0.02% 445
2015
Q3
$772K Sell
162
-9,638
-98% -$627K 0.01% 199
2015
Q2
$658K Sell
9,800
-1,700
-15% -$111K 0.01% 394
2015
Q1
$673K Sell
11,500
-200
-2% -$12.1K 0.02% 335
2014
Q4
$766K Buy
11,700
+4,600
+65% +$290K 0.02% 369
2014
Q3
$410K Buy
7,100
+4,700
+196% +$261K 0.01% 438
2014
Q2
$135K Buy
+2,400
New +$126K 0.01% 596
2014
Q1
Sell
-14,200
Closed -$750K 722
2013
Q4
$750K Buy
+14,200
New +$698K 0.07% 294

Other funds holding ABBV

Jump Trading's ABBV Position: Q2 2020 in Review

Jump Trading reduced its AbbVie (ABBV) stake by 76% in Q2 2020, selling an estimated $594K and leaving 2,102 shares worth $206K. The position accounts for 0.14% of the portfolio, ranked #192.

Jump Trading first reported a position in ABBV in Q4 2013 and has held it in 11 quarters since. The position peaked at $692K in Q1 2015. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Jump Trading held 2,102 shares of AbbVie worth $206K as of Q2 2020.
  • Jump Trading sold 6,744 AbbVie shares in Q2 2020, an estimated $594K.
  • AbbVie made up 0.14% of Jump Trading's portfolio in Q2 2020, its #192 holding.
  • Jump Trading first reported a position in AbbVie in Q4 2013 and has held it in 11 quarters since.
  • Jump Trading's AbbVie position peaked at $692K in Q1 2015.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.